This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Massachusetts Institute of Technology. Active years: 1996-2011.
Company Filing History:
Years Active: 1996-2011
Title: The Innovations of David L Beeler
Introduction
David L Beeler is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapies for blood platelet disorders. With a total of 2 patents, his work has the potential to impact medical treatments and improve patient outcomes.
Latest Patents
One of Beeler's latest patents is focused on 6-O sulfated polysaccharides and methods of preparation thereof. This patent discloses methods for 6-O-sulfating glucosaminyl N-acetylglucosamine residues (GlcNAc) in a polysaccharide preparation. It also includes methods for converting anticoagulant-inactive heparan sulfate to anticoagulant-active heparan sulfate. Additionally, the patent describes a mutant CHO cell that hyper-produces anticoagulant-active heparan sulfate. Furthermore, methods for elucidating the sequence of activity of enzymes in a biosynthetic pathway are provided.
Another significant patent by Beeler involves the method of using megapoietin for prolonging the survival and viability of blood platelets. This patent describes new therapies for treating blood platelet disorders based on the megapoietin gene and protein. It outlines additional utilities for megapoietin, such as increasing the storage life of platelet and whole blood preparations, selectively targeting therapeutic or imaging agents to arterial clots, and stimulating platelet production from megakaryocytes in vivo and in vitro.
Career Highlights
David L Beeler is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research and innovations. His work is characterized by a strong focus on improving medical treatments and understanding complex biological processes.
Collaborations
Beeler has collaborated with notable colleagues, including Robert D Rosenberg and David J Kuter. These collaborations have contributed to the development of his innovative patents and research initiatives.
Conclusion
David L Beeler's contributions to the field of biomedical research through his patents and collaborations highlight his commitment to advancing medical science. His work has the potential to significantly improve therapies for blood platelet disorders and enhance patient care.